Skip to content

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Enhancing Aphasia Therapy With Anodal Transcranial Direct Current Stimulation in Chronic Stroke Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02461355
Enrollment
2
Registered
2015-06-03
Start date
2015-06-30
Completion date
2016-06-30
Last updated
2019-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.

Interventions

BEHAVIORALAphasia therapy

Aphasia therapy using a computerized scripting program

DEVICEAnodal tDCS

Anodal transcranial direct current stimulation using the Chattanooga Ionto device

DEVICESham tDCS

Sham transcranial direct current stimulation using the Chattanooga Ionto device

Sponsors

Pitkin Foundation
CollaboratorUNKNOWN
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age over 21 years 2. Ischemic left hemispheric stroke verified by imaging (CT or MRI) greater than 6 months ago 3. Residual non-fluent or anomic aphasia, with Western Aphasia Battery-Revised Aphasia Quotient score \<60 4. Fluent English speaker prior to stroke 5. Right-handed prior to stroke 6. Ability to give informed consent and understand the tasks involved.

Exclusion criteria

1. History of recurrent stroke, either ischemic or hemorrhagic, in the left middle cerebral artery territory 2. Imaging unavailable 3. Large middle cerebral artery infarct involving entire inferior division (temporo-parietal) territory 4. History of dementia prior to the stroke 5. History of seizure, prior electroconvulsive therapy, deep brain stimulators, or brain surgery 6. Social and/or personal circumstances that interfere with ability to return for therapy and assessment sessions.

Design outcomes

Primary

MeasureTime frame
Change in Percent Correct of Trained ScriptsFrom Baseline to up to 2 days post-training
Change in Words Per Minute of Trained ScriptsFrom Baseline to up to 2 days post-training

Secondary

MeasureTime frame
Change in Percent Correct of Trained ScriptsBaseline to 2 weeks and 4 weeks post-training
Change in Words Per Minute of Trained ScriptsBaseline to 2 weeks and 4 weeks post-training

Other

MeasureTime frame
Change in Percent Script Words OmittedBaseline to immediate, 2 weeks, and 4 weeks post-training

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
Includes participants who received anodal transcranial direct current stimulation (tDCS) or sham tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions.
2
Total2

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
2 Participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 2
other
Total, other adverse events
0 / 2
serious
Total, serious adverse events
0 / 2

Outcome results

Primary

Change in Percent Correct of Trained Scripts

Time frame: From Baseline to up to 2 days post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Primary

Change in Words Per Minute of Trained Scripts

Time frame: From Baseline to up to 2 days post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Secondary

Change in Percent Correct of Trained Scripts

Time frame: Baseline to 2 weeks and 4 weeks post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Secondary

Change in Words Per Minute of Trained Scripts

Time frame: Baseline to 2 weeks and 4 weeks post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Other Pre-specified

Change in Percent Script Words Omitted

Time frame: Baseline to immediate, 2 weeks, and 4 weeks post-training

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026